Document 0486 DOCN M9480486 TI Transcriptional suppression of the human T-cell leukemia virus type I long terminal repeat occurs by an unconventional interaction of a CREB factor with the R region. DT 9410 AU Xu X; Brown DA; Kitajima I; Bilakovics J; Fey LW; Nerenberg MI; Department of Neuropharmacology, Scripps Research Institute, La; Jolla, California 92037. SO Mol Cell Biol. 1994 Aug;14(8):5371-83. Unique Identifier : AIDSLINE MED/94309657 AB To analyze regulation of the human T-cell leukemia virus type I (HTLV-I) long terminal repeat (LTR), cell lines were generated from LTR-tax x LTR-beta-galactosidase (beta-Gal) doubly transgenic mouse fibroblastic tumors. The HTLV-I LTR directs expression of both the tax and lacZ genes, and Tax up-modulates both promoters in primary cells. However, once cells were transformed by tax, beta-Gal but not tax expression was suppressed. Supertransformation of these cells with v-src suppressed both beta-Gal and tax expression. This suppression was reversed by treatment with the tyrosine kinase inhibitor herbimycin A or protein kinase A inhibitor H8. Electrophoretic mobility shift assays demonstrated augmented binding in the R but not U3 region. This binding was competitively inhibited by a high-affinity CREB oligodeoxynucleotide and super-shifted with a specific CREB antibody. Treatment of cells with the cyclic AMP analog dibutyryl cyclic AMP also transiently increased the R region binding dramatically. In vitro DNase I footprint analysis identified a protein-binding sequence in the R region which corresponded with suppression. However, this target sequence lacked a conventional CREB-binding site. A 70.5-kDa DNA-binding protein was partially purified by affinity chromatography, along with a 49-kDa protein which reacted with CREB-specific sera. These data demonstrate that HTLV-I LTR suppression is associated with CREB factor binding in the R region, probably by direct interaction with a 70.5-kDa protein, and provide a novel mechanism for maintenance of viral latency. DE Animal Base Sequence Binding Sites Cyclic AMP-Dependent Protein Kinases/METABOLISM DNA-Binding Protein, Cyclic AMP-Responsive/*METABOLISM DNA-Binding Proteins/METABOLISM *Gene Expression Regulation, Viral Genes, pX Genes, src HTLV-I/*GENETICS Mice Mice, Transgenic Molecular Sequence Data Nuclear Proteins/METABOLISM *Repetitive Sequences, Nucleic Acid RNA, Messenger/GENETICS Support, Non-U.S. Gov't Support, U.S. Gov't, P.H.S. Transcription, Genetic JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).